Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Trading Floor Community IconFrom the Trading Floor:
Ionis Pharmaceuticals Inc Logo

Combined Holdings of Ionis Pharmaceuticals (IONS) - Updated Daily

Lock IconJoin Premium Plan
The Bucket Report Icon
Download ARK WatchlistsDownload ARK holdings as watchlists that can be imported into TradingView and Interactive Brokers
Date
Direction
Shares
Fund Weight
Fund
June 9, 2022SELL60.000k0.0817%ARKG
June 8, 2022SELL74.115k0.1034%ARKG
June 7, 2022SELL31.146k0.044%ARKG
June 6, 2022SELL313.0000.0005%ARKG
June 3, 2022SELL57.657k0.0825%ARKG

Key Statistics

Upcoming EarningsSee Full Calendar
DateAugust 02, 2022(Est)Revenue
Expected$140.84m
Actual▫️
EPS
Expected-$0.62
Actual▫️
🕵🏼Found In🏷Last Price
ARKG$38.06
⚖️Weighting🧢Market Cap
1%$5.40b
🏋️‍♀️Weight Rank Across All Funds🧮Price to Sales
236.42
💳ARK Estimated Cost Average🌏Country
$43.70 - ARKG
🇺🇸United States
🎫ARK Ownership Percent
3.07%
Description
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Its scientific innovation began and continues with the knowledge that sick people depend on it, which fuels its vision of becoming one of the most successful biotechnology companies.
Website
www.ionispharma.com